Adverse Effects Associated with the Use of Antihypertensive Drugs: An Overview

Joshi, Vishal D.; Dahake, Akash P.; Suthar, Ashok P.
January 2010
International Journal of PharmTech Research;Jan-Mar2010, Vol. 2 Issue 1, p10
Academic Journal
Hypertension is one of the most important cardiovascular risk factor but its control is still Challenge for physicians all around the world. Antihypertensive are a class of drugs that are used in medicine and pharmacology to treat hypertension (high blood pressure). All Hypertensive drugs cause dizziness, ankle swelling, headache, fatigue, chest discomfort and cough. This review focus on the adverse effects of Antihypertensive drugs, severity of these adverse effects and attempts made to prevention and treatment of hypertension by non-pharmacological intervention.


Related Articles

  • Hypertension Management: An Update. Quang Nguyen; Dominguez, Joann; Loida Nguyen; Gullapalli, Nageshwara // American Health & Drug Benefits;Jan2010, Vol. 3 Issue 1, p47 

    Hypertension is a significant and costly public health problem. It is a major, but modifiable contributor for the development of cardiovascular disease. Randomized controlled trials have shown that controlling hypertension reduces the risk of stroke, coronary artery disease, congestive heart...

  • The Influence of Oseltamivir Treatment on the Risk of Stroke after Influenza Infection. Madjid, Mohammad; Curkendall, Suellen; Blumentals, William A. // Cardiology;2009, Vol. 113 Issue 2, p98 

    Objectives: It was the aim of this study to examine the influence of the antiviral medication oseltamivir on stroke and transient ischemic attack (TIA) in adults diagnosed with influenza. Methods: This retrospective cohort study used medical and pharmaceutical claims data from May 2000 to...

  • The relationship between diabetes and atherosclerosis. Beckwith, Sue // British Journal of Cardiac Nursing;May2014, Vol. 9 Issue 5, p237 

    Diabetes is characterised by accelerated atherosclerosis with widely distributed vascular lesions. Both the risk and rate of development of these lesions are directly influenced by the glycaemic fluctuations and lipid imbalances characteristic of diabetes. This article looks at the mechanisms...

  • General practice workload implications of the national service framework for coronary heart disease: cross sectional survey. Toop; Richards; Hippisley-Cox, Julia; Pringle, Mike // BMJ: British Medical Journal (International Edition);8/4/2001, Vol. 323 Issue 7307, p269 

    Reports on a study to estimate the general practice workload involved in meeting the goals of Great Britain's national service framework for coronary heart disease. Goal of the framework to identify all patients at risk for coronary heart disease and stroke and offer appropriate treatment;...

  • RYR3 gene polymorphisms and cardiovascular disease outcomes in the context of antihypertensive treatment. Lynch, A I; Irvin, M R; Boerwinkle, E; Davis, B R; Vaughan, L K; Ford, C E; Aissani, B; Eckfeldt, J H; Arnett, D K; Shrestha, S // Pharmacogenomics Journal;Aug2013, Vol. 13 Issue 4, p330 

    Nearly one-third of adults in the United States have hypertension, which is associated with increased cardiovascular disease (CVD) morbidity and mortality. The goal of antihypertensive pharmacogenetic research is to enhance understanding of drug response based on the interaction of individual...

  • Effects of Antihypertensive Drugs on Central Blood Pressure in Humans: A Preliminary Observation. Agnoletti, Davide; Zhang, Yi; Borghi, Claudio; Blacher, Jacques; Safar, Michel E. // American Journal of Hypertension;Aug2013, Vol. 26 Issue 8, p1045 

    BACKGROUND Central blood pressure (BP) is considered a better predictor of cardiovascular events than brachial BP. Modifications of central, beyond brachial BP, can be assessed by pressure amplification, a potential new cardiovascular risk factor. Comparison between drugs’ effect on...

  • Inhibitory Effects of Azelnidipine Tablets on Morning Hypertension. Kario, Kazuomi; Sato, Yuki; Shirayama, Masayuki; Takahashi, Megumi; Shiosakai, Kazuhito; Hiramatsu, Katsutoshi; Komiya, Masahiro; Shimada, Kazuyuki // Drugs in R&D;2013, Vol. 13 Issue 1, p63 

    Background: Morning hypertension is a risk factor for cardiovascular and cerebrovascular events. Furthermore, it is a useful measure for definitive diagnosis of hypertension, and patients who self-assess their own blood pressure (BP) in the morning tend to exhibit better compliance with...

  • Mortality from cardiovascular disease among interregional migrants in England and Wales. Strachan, D.P.; Leon, D.A. // BMJ: British Medical Journal (International Edition);2/18/95, Vol. 310 Issue 6977, p423 

    Investigates the extent to which geographical variations in mortality from ischemic heart disease and stroke in Great Britain are influenced by factors in early life or in adulthood. Genetic factors; Environmental exposures; Lifestyle.

  • Role of Lp(a) in coronary disease and stroke is controversial. Dale, David C.; Federman, Daniel D. // Cortlandt Forum;03/25/98, Vol. 11 Issue 3, p28 

    Presents studies suggesting that lipoprotein (a) (Lp[a]) is a risk factor for coronary artery disease (CAD) and stroke. Differences in measurement methods; Possibility that Lp(a) may increase risk only in people with hypercholesterolemia; Reduction of elevated low-density lipoprotein...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics